| Dynamics of clonal evolution in myelodysplastic syndromes H Makishima, T Yoshizato, K Yoshida, MA Sekeres, T Radivoyevitch, ... Nature genetics 49 (2), 204-212, 2017 | 429 | 2017 |
| Dynamics of clonal evolution in myelodysplastic syndromes H Makishima, T Yoshizato, K Yoshida, MA Sekeres, T Radivoyevitch, ... Nature genetics 49 (2), 204-212, 2017 | 429 | 2017 |
| 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors T Korytko, T Radivoyevitch, V Colussi, BW Wessels, K Pillai, RJ Maciunas, ... International Journal of Radiation Oncology* Biology* Physics 64 (2), 419-424, 2006 | 337 | 2006 |
| Genetic alterations of the cohesin complex genes in myeloid malignancies S Thota, AD Viny, H Makishima, B Spitzer, T Radivoyevitch, ... Blood, The Journal of the American Society of Hematology 124 (11), 1790-1798, 2014 | 269 | 2014 |
| The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation RJ Molenaar, T Radivoyevitch, JP Maciejewski, CJF van Noorden, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (2), 326-341, 2014 | 223 | 2014 |
| SBML Level 3: an extensible format for the exchange and reuse of biological models SM Keating, D Waltemath, M König, F Zhang, A Dräger, C Chaouiya, ... Molecular systems biology 16 (8), e9110, 2020 | 205 | 2020 |
| Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis TJ Alban, AG Alvarado, MD Sorensen, D Bayik, J Volovetz, E Serbinowski, ... JCI insight 3 (21), 2018 | 170 | 2018 |
| Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes A Nazha, M Narkhede, T Radivoyevitch, DJ Seastone, BJ Patel, AT Gerds, ... Leukemia 30 (11), 2214-2220, 2016 | 170 | 2016 |
| Cardiovascular safety profile of combretastatin a4 phosphate in a single-dose phase I study in patients with advanced cancer MM Cooney, T Radivoyevitch, A Dowlati, B Overmoyer, N Levitan, ... Clinical Cancer Research 10 (1), 96-100, 2004 | 157 | 2004 |
| Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198 RJ Molenaar, D Botman, MA Smits, VV Hira, SA van Lith, J Stap, ... Cancer research 75 (22), 4790-4802, 2015 | 153 | 2015 |
| Biochemical systems analysis of genome-wide expression data EO Voit, T Radivoyevitch Bioinformatics 16 (11), 1023-1037, 2000 | 147 | 2000 |
| Increased CDA expression/activity in males contributes to decreased cytidine analog half-life and likely contributes to worse outcomes with 5-azacytidine or decitabine therapy RZ Mahfouz, A Jankowska, Q Ebrahem, X Gu, V Visconte, A Tabarroki, ... Clinical cancer research 19 (4), 938-948, 2013 | 140 | 2013 |
| Risk of hematologic malignancies after radioiodine treatment of well-differentiated thyroid cancer RJ Molenaar, S Sidana, T Radivoyevitch, AS Advani, AT Gerds, ... Journal of clinical oncology 36 (18), 1831, 2018 | 135 | 2018 |
| Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: a randomized phase 1 study R Molokie, D Lavelle, M Gowhari, M Pacini, L Krauz, J Hassan, V Ibanez, ... PLoS medicine 14 (9), e1002382, 2017 | 133 | 2017 |
| Bleeding incidence and risk factors among cancer patients treated with anticoagulation DE Angelini, T Radivoyevitch, KR McCrae, AA Khorana American journal of hematology 94 (7), 780-785, 2019 | 115 | 2019 |
| Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells F Pan, TS Wingo, Z Zhao, R Gao, H Makishima, G Qu, L Lin, M Yu, ... Nature communications 8 (1), 15102, 2017 | 115 | 2017 |
| Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates X Gu, Q Ebrahem, RZ Mahfouz, M Hasipek, F Enane, T Radivoyevitch, ... The Journal of clinical investigation 128 (10), 4260-4279, 2018 | 108 | 2018 |
| Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms RJ Molenaar, S Thota, Y Nagata, B Patel, M Clemente, B Przychodzen, ... Leukemia 29 (11), 2134-2142, 2015 | 102 | 2015 |
| Reduced expression of NFAT-associated genes in UCB versus adult CD4+ T lymphocytes during primary stimulation BA Kaminski, S Kadereit, RE Miller, P Leahy, KR Stein, DA Topa, ... Blood 102 (13), 4608-4617, 2003 | 101 | 2003 |
| IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors RJ Molenaar, T Radivoyevitch, Y Nagata, M Khurshed, B Przychodzen, ... Clinical cancer research 24 (7), 1705-1715, 2018 | 98 | 2018 |
jarek maciejewskiVerified email at ccf.org
